About: Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.36 (-10.00%)
CMB ASX Cambium Bio Ltd
Cambium Bio Ltd share price
Atividade de preço de CMB
Último preço
$ 0,360
Variação (24h)
-0,04 AUD (10,00%)
Volume
515
Volume (média 4 sem.)
-
Abertura
$ 0,36
Variação do dia
$ 0,36 - $ 0,36
Fechamento anterior
$ 0,40
Último negócio
04 Nov, 4:59 am GMT+0
Atrasado
04 Nov, 4:59 am GMT+0
CMB price performance
Atrasado
04 Nov, 4:59 am GMT+0
CMB details
quote.marketSignals